Compound Detail
CHEMBL9926
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL9926 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | NGRMAEVNKSNJKE-UKTHLTGXSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
370.4
MW (Da)
3.77
ALogP
6
HBA
0
HBD
63.2
PSA (Ų)
0.57
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 7.92
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| K562 CHEMBL385 | IC50 | 7.92 | 7.92 | 12.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| K562 | IC50 | = | 12.0 | nM | 7.92 | Compound was evaluated for cytotoxic activity against K562 human chronic myeloge... | 9871706 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 9871706 | 10.1016/s0960-894x(98)00162-0 | K562 | 1 |
Data from ChEMBL 36 via Core Engine